Nanalysis Scientific Corp.
NSCIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,208 | $36,502 | $63,469 | $84,371 |
| - Cash | $1,376 | $759 | $3,525 | $10,405 |
| + Debt | $18,361 | $21,968 | $10,753 | $5,985 |
| Enterprise Value | $51,193 | $57,711 | $70,697 | $79,951 |
| Revenue | $45,495 | $28,466 | $24,821 | $16,043 |
| % Growth | 59.8% | 14.7% | 54.7% | – |
| Gross Profit | $12,746 | $3,971 | $10,469 | $10,240 |
| % Margin | 28% | 13.9% | 42.2% | 63.8% |
| EBITDA | -$7,664 | -$8,848 | -$5,261 | $1,376 |
| % Margin | -16.8% | -31.1% | -21.2% | 8.6% |
| Net Income | -$13,613 | -$16,784 | -$9,915 | -$1,772 |
| % Margin | -29.9% | -59% | -39.9% | -11% |
| EPS Diluted | -0.12 | -0.16 | -0.11 | -0.033 |
| % Growth | 25% | -45.5% | -229.3% | – |
| Operating Cash Flow | $3,263 | -$11,185 | -$8,546 | -$1,199 |
| Capital Expenditures | -$1,858 | -$4,592 | -$7,201 | -$3,004 |
| Free Cash Flow | $1,405 | -$15,777 | -$15,556 | -$4,203 |